2.58 -0.02 (-0.77%)
4:00 PM ET 12/04/09
Company Profile
Price and Volume
Recent Price 2.58
52 Week High 8.43
52 Week Low 1.44
Avg. Daily Vol. (Mil) 0.64
Beta (3 year) -1.09
Share Related Items
Mkt Cap (Mil) 96.26
Shares Out (Mil) 37.31
Float (Mil) 35.95
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.80
Current Ratio 2.90
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 5.27
Price/Cash Flow -3.20
Per Share Data
Earnings -1.02
Sales 0.00
Book Value 0.49
Cash Flow -0.82
Business Summary
A clinical-stage biopharmaceutical company, which is engaged in the development of medicines in the areas of hepatitis C and oncology.
General Information
3115 Merryfield Row
San Diego, CA 92121
www.anadyspharma.com
Industry : Drugs
Sector: Health Care
Employees: 47
CEO: Dr. Stephen T. Worland,
Short Interest
Current Month (Mil) 1.43
Previous Month (Mil) 1.40
Short Interest Ratio (Days) 3.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -115.60
Return on Investments -172.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Dow Jones S&P 500 NASDAQ 10-Year Note
10,388.90 1,105.98 2,194.35 34.83
Oil *
77.74
UP
22.75
UP
6.06
UP
21.21
UP
1.03
10 Yr
3.48%
SPDR Gold
113.75
+0.22%
+0.55%
+0.98%
+3.05%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services